Research Projects & Grants

Internal

• Predictors of hypomagnesemia with denosumab in patients with metastatic bone disease from solid malignancies: A single-institution retrospective study, Role: PI, LLU Dept. of Pharmacy Practice, (11/2023) Status: Approved
• Assessment of Utilization Patterns of Novel Hormonal Therapy (NHT) Agents in Non-metastatic Prostate Cancer, Role: Investigator, LLU Dept. of Pharmacy Practice, (12/2021 - 12/2025) Status: Completed
• Daily Dosing of Acyclovir for Viral Infection Prophylaxis in Patients with Hematologic Malignancy, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2020) Status: Approved
• Risk Factors of Hypomagnesemia in Patients with Bone Metastases from Solid Malignancies Treated with Zoledronic Acid: A Single-institution Retrospective Study, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved
• Cost analysis of subcutaneous daratumumab compared to intravenous daratumumab in multiple myeloma patients: A retrospective chart review, Role: Investigator, LLU Dept. of Pharmacy Practice, (11/2024) Status: Approved
• A low-dose prophylactic regimen of oral dexamethasone versus the standard package insert recommended dose for the prevention of fluid retention and hypersensitivity reactions in docetaxel-treated solid tumor patients: A retrospective chart review., Role: Investigator, LLU School of Pharmacy, (12/2025) Status: Approved